Family Dollar Laxative Products Recalled for Improper Storage Conditions
Family Dollar recalls two bisacodyl laxative products (SKUs 902449 and 915221) distributed to specific stores from April to June 2022 due to storage temperature deviations affecting product quality.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves storage temperature deviations with no reported illnesses or adverse events. The hazard relates to product quality and efficacy rather than direct safety risk, consistent with precautionary recall guidance.
Plain-English summary
Family Dollar Stores, LLC, is recalling QP LAXATIVE BISACODYL 5 MG TABLET 50 CT (SKU 902449) and QP WOMEN LAXATIVE BISACODYL TABLET 25 CT (SKU 915221) due to Current Good Manufacturing Practice (CGMP) deviations. The products were held outside appropriate storage temperature conditions during distribution, which may affect product quality and efficacy.
These products were distributed to specific Family Dollar Stores between April 30, 2022, and June 10, 2022. Consumers who purchased these products should stop using them and contact their local Family Dollar Store with questions.
For more information, consumers may contact Family Dollar Stores or the FDA. Healthcare providers and consumers can report adverse events to the FDA's MedWatch program.
The recalled product
- Product
- QP LAXATIVE BISACODYL 5 MG TABLET 50 CT SKU 902449 QP WOMEN LAXATIVE BISCODYL TABLET 25 CT SKU 915221 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- storage-temperature-deviation
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 902449
- 915221
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27